← Back to Search

MedSupport for Medication Adherence in Pediatric Cancer

N/A

Waitlist Available

Led By Elizabeth Bouchard, MD

Research Sponsored by Roswell Park Cancer Institute

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Parents/guardians of child that has been diagnosed with any cancer

Parents/guardians of child on home-based oral anti-cancer therapy or supportive care therapy

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to 8 weeks

Awards & highlights

Study Summary

This trial aims to improve treatment adherence and outcomes in pediatric cancer survivors by developing and implementing a cancer center intervention.

Who is the study for?

This trial is for parents or guardians of children aged 0-18 with any type of cancer who are on home-based oral anti-cancer or supportive care therapy. The child's clinician must agree to participate. Participants must be able to complete assessments in English.Check my eligibility

What is being tested?

The study is testing a virtual intervention aimed at helping parents and guardians improve how they manage their child’s medication schedule, with the goal of promoting better adherence to treatment plans in pediatric cancer patients.See study design

What are the potential side effects?

Since this trial focuses on a virtual intervention rather than a medical treatment, traditional physical side effects are not expected. However, participants may experience stress or anxiety related to managing medication adherence.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

My child has been diagnosed with cancer.

Select...

I am a parent/guardian of a child on cancer treatment at home.

Select...

I am the parent/guardian of a child aged 0-18 with cancer.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to 8 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to 8 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 8 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Retention rates

Secondary outcome measures

Feasibility of universal SDOA screening

Provider satisfaction with barrier reports

Trial Design

2Treatment groups

Experimental Treatment

Group I: Intervention - Pediatric parent/caregiverExperimental Treatment1 Intervention

Questionnaires along with educational videos

Group II: CliniciansExperimental Treatment1 Intervention

Will complete pre and post survey about medication education practices

0 / 3Eligibility criteria met

Find a Location

Who is running the clinical trial?

Roswell Park Cancer InstituteLead Sponsor

402 Previous Clinical Trials

30,841 Total Patients Enrolled

Elizabeth Bouchard, MDPrincipal InvestigatorRoswell Park Comprehensive Cancer Center

2 Previous Clinical Trials

136 Total Patients Enrolled

Media Library

Patient participation Clinical Trial Eligibility Overview. Trial Name: NCT05150028 — N/A

Medication Adherence Research Study Groups: Intervention - Pediatric parent/caregiver, Clinicians

Medication Adherence Clinical Trial 2023: Patient participation Highlights & Side Effects. Trial Name: NCT05150028 — N/A

Patient participation 2023 Treatment Timeline for Medical Study. Trial Name: NCT05150028 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the recruitment of participants for this trial currently underway?

"Affirmative, the data hosted on clinicaltrials.gov suggests that this medical experiment is currently enrolling patients; it was initially posted in July 1st 2022 and modified a few weeks ago (October 20th). The investigation requires 30 volunteers at one location for its completion."

Answered by AI

How many participants are currently participating in this research endeavor?

"Affirmative. According to the clinicaltrials.gov record, this clinical trial is currently recruiting participants since it was first uploaded on July 1st 2022 and last modified on October 20th 2022. The study needs to recruit 30 individuals from a single medical facility."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

A Virtual Intervention to Improve Medication Adherence in Pediatric Cancer: MedSupport

2023. "A Virtual Intervention to Improve Medication Adherence in Pediatric Cancer: MedSupport". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05150028.

All > Pediatric Cancer